Skip to main content

Advertisement

SpringerLink
Log in

Preparing the Child with End-Stage Renal Disease for a Renal Transplant: the Pre-transplant Assessment

  • Renal (D Noone, Section Editor)
  • Published:
Current Pediatrics Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

We review the pre-transplant assessment of the renal transplant candidate, highlighting specific issues that are unique to the pediatric patient.

Recent Findings

The pre-transplant assessment consists of a thorough history and physical examination, supplemented by laboratory evaluations based on a systems-based approach. Considerations that are unique to the pediatric population include the assessment of immunization, nutritional and developmental status, as well as for underlying urological abnormalities that require management prior to transplantation.

Summary

A thorough and complete pre-transplant assessment identifies comorbidities that require management prior to transplantation, anticipates potential risks and complications peri- and post-transplant, and facilitates planning for risk mitigating strategies and post-transplant management to maximize allograft and patient survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–30.

    CAS  PubMed  Google Scholar 

  2. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med. 1994;331(6):365–76.

    CAS  PubMed  Google Scholar 

  3. McDonald SP, Craig JC. Australian, New Zealand paediatric nephrology a. long-term survival of children with end-stage renal disease. N Engl J Med. 2004;350(26):2654–62.

    CAS  PubMed  Google Scholar 

  4. Fine RN, Martz K, Stablein D. What have 20 years of data from the North American pediatric renal transplant cooperative study taught us about growth following renal transplantation in infants, children, and adolescents with end-stage renal disease? Pediatr Nephrol (Berlin). 2010;25:739–46.

    Google Scholar 

  5. Pape L, Ehrich JHH, Zivicnjak M, Offner G. Growth in children after kidney transplantation with living related donor graft or cadaveric graft. Lancet. 2005;366:151–3.

    CAS  PubMed  Google Scholar 

  6. Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D, et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2001;1(Suppl 2):3–95.

    Google Scholar 

  7. Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005;173(10):1181–4.

    PubMed  PubMed Central  Google Scholar 

  8. Bunnapradist S, Danovitch GM. Evaluation of adult kidney transplant candidates. Am J Kidney Dis. 2007;50(5):890–8.

    PubMed  Google Scholar 

  9. Maggiore U, Abramowicz D, Budde K, Crespo M, Mariat C, Oberbauer R, et al. Standard work-up of the low-risk kidney transplant candidate: a European expert survey of the ERA-EDTA developing education science and care for renal transplantation in European states working group. Nephrol Dial Transplant. 2019;34(9):1605–11.

    PubMed  Google Scholar 

  10. Campbell S, Pilmore H, Gracey D, Mulley W, Russell C, McTaggart S. KHA-CARI guideline: recipient assessment for transplantation. Nephrology. 2013;18(6):455–62.

    PubMed  Google Scholar 

  11. Abramowicz D, Cochat P, Claas FH, Heemann U, Pascual J, Dudley C, et al. European renal best practice guideline on kidney donor and recipient evaluation and perioperative care. Nephrol Dial Transplant. 2015;30(11):1790–7.

    PubMed  Google Scholar 

  12. Martens MA, Jones L, Reiss S. Organ transplantation, organ donation and mental retardation. Pediatr Transplant. 2006;10(6):658–64.

    PubMed  Google Scholar 

  13. Chen A, Farney A, Russell GB, Nicolotti L, Stratta R, Rogers J, et al. Severe intellectual disability is not a contraindication to kidney transplantation in children. Pediatr Transplant. 2017;21(3).

  14. Amaral S, Sayed BA, Kutner N, Patzer RE. Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease. Kidney Int. 2016;90(5):1100–8.

    PubMed  PubMed Central  Google Scholar 

  15. Vats AN, Donaldson L, Fine RN, Chavers BM. Pre-transplant dialysis status and outcome of renal transplantation in North American children: a NAPRTCS STUDY12. Transplantation. 2000;69(7):1414–9.

    CAS  PubMed  Google Scholar 

  16. Montgomery JR, Berger JC, Warren DS, James NT, Montgomery RA, Segev DL. Outcomes of ABO-incompatible kidney transplantation in the United States. Transplantation. 2012;93(6):603–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Masterson R, Hughes P, Walker RG, Hogan C, Haeusler M, Robertson AR, et al. ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14(12):2807–13.

    CAS  Google Scholar 

  18. Rydberg L. ABO-incompatibility in solid organ transplantation. Transfus Med. 2001;11(4):325–42.

    CAS  PubMed  Google Scholar 

  19. Hattori M, Mieno M, Shishido S, Aikawa A, Ushigome H, Ohshima S, et al. Outcomes of pediatric ABO-incompatible living kidney transplantations from 2002 to 2015: an analysis of the Japanese kidney transplant registry. Transplantation. 2018;102(11):1934–42.

    PubMed  Google Scholar 

  20. Kawamura T, Hamasaki Y, Takahashi Y, Hashimoto J, Kubota M, Muramatu M, et al. ABO-incompatible pediatric kidney transplantation without antibody removal. Pediatr Nephrol. 2020;35(1):95–102.

    PubMed  Google Scholar 

  21. Stojanovic J, Adamusiak A, Kessaris N, Chandak P, Ahmed Z, Sebire NJ, et al. Immune desensitization allows pediatric blood group incompatible kidney transplantation. Transplantation. 2017;101(6):1242–6.

    CAS  PubMed  Google Scholar 

  22. •• Reynolds BC, Tinckam KJ. Sensitization assessment before kidney transplantation. Transplant Rev. 2017;31(1):18–28 A very comprehensive review of the sensitization assessment before transplantation.

    Google Scholar 

  23. Dunn TB, Noreen H, Gillingham K, Maurer D, Ozturk OG, Pruett TL, et al. Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant. 2011;11(10):2132–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Wehmeier C, Honger G, Cun H, Amico P, Hirt-Minkowski P, Georgalis A, et al. Donor specificity but not broadness of sensitization is associated with antibody-mediated rejection and graft loss in renal allograft recipients. Am J Transplant. 2017;17(8):2092–102.

    CAS  PubMed  Google Scholar 

  25. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969;280(14):735–9.

    CAS  PubMed  Google Scholar 

  26. Orandi BJ, Garonzik-Wang JM, Massie AB, Zachary AA, Montgomery JR, Van Arendonk KJ, et al. Quantifying the risk of incompatible kidney transplantation: a multicenter study. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14(7):1573–80.

    CAS  Google Scholar 

  27. Wiebe C, Nickerson PW. Human leukocyte antigen molecular mismatch to risk stratify kidney transplant recipients. Curr Opin Organ Transplant. 2020;25(1):8–14.

    CAS  PubMed  Google Scholar 

  28. Philogene MC, Amin A, Zhou S, Charnaya O, Vega R, Desai N, et al. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis. Pediatr Nephrol. 2020;35(1):83–94.

    PubMed  Google Scholar 

  29. Wiebe C, Rush DN, Nevins TE, Birk PE, Blydt-Hansen T, Gibson IW, et al. Class II eplet mismatch modulates tacrolimus trough levels required to prevent donor-specific antibody development. J Am Soc Nephrol. 2017;28(11):3353–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Sapir-Pichhadze R, Tinckam K, Quach K, Logan AG, Laupacis A, John R, et al. HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study. Am J Transplant. 2015;15(1):137–48.

    CAS  PubMed  Google Scholar 

  31. • Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, et al. Sensitization in transplantation: assessment of risk (STAR) 2017 working group meeting report. Am J Transplant. 2018;18(7):1604–14 Summary and recommendations from the STAR meeting which discuss HLA diagnostic testing and framework for clinical assessment of risk for memory and primary alloimmune response.

    PubMed  Google Scholar 

  32. Allen UD, Preiksaitis JK, Practice ASTIDCo. Epstein-Barr virus and post-transplant lymphoproliferative disorder in solid organ transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2013;13(Suppl 4):107–20.

    CAS  Google Scholar 

  33. Razonable RR, Humar A. Practice ASTIDCo. Cytomegalovirus in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:93–106.

    CAS  PubMed  Google Scholar 

  34. Shroff RC, McCulloch M, Novelli V, Shingadia D, Bradley S, Clapson M, et al. Successful outcome of renal transplantation in a child with HIV-associated nephropathy. Arch Dis Child. 2014;99(11):1026–8.

    PubMed  Google Scholar 

  35. Segall L, Covic A. Diagnosis of tuberculosis in dialysis patients: current strategy. Clin J Am Soc Nephrol. 2010;5(6):1114–22.

    CAS  PubMed  Google Scholar 

  36. Scandling JD. Kidney transplant candidate evaluation. Semin Dial. 2005;18(6):487–94.

    PubMed  Google Scholar 

  37. •• L'Huillier AG, Green M, Danziger-Isakov L, Chaudhuri A, Hocker B, Van der Linden D, et al. Infections among pediatric transplant candidates: an approach to decision-making. Pediatr Transplant. 2019;23(3):e13375 A very helpful guide for the clinician.

    PubMed  Google Scholar 

  38. • Danziger-Isakov L, Kumar D. Practice AICo. Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transpl. 2019;33(9):e13563 Important reference to review current guidelines on immunization in transplantation.

    Google Scholar 

  39. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309–18.

    PubMed  Google Scholar 

  40. Abuali MM, Arnon R, Posada R. An update on immunizations before and after transplantation in the pediatric solid organ transplant recipient. Pediatr Transplant. 2011;15(8):770–7.

    CAS  PubMed  Google Scholar 

  41. Publicly funded immunization schedules for Ontario. 2016.

  42. National Advisory Committee on Immunization. Canadian Immunization Guide. 2018.

  43. Danziger-Isakov L, Kumar D. Practice ASTIDCo. Vaccination in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:311–7.

    CAS  PubMed  Google Scholar 

  44. L'Huillier AG, Kumar D. Immunizations in solid organ and hematopoeitic stem cell transplant patients: a comprehensive review. Hum Vaccin Immunother. 2015;11(12):2852–63.

    PubMed  PubMed Central  Google Scholar 

  45. GlaxoSmithKline Inc. Product monograph-Priorix. 2018.

  46. Advisory Committee on Immunization Practices. Recommended immunization schedule for children and adolescents aged 18 years or younger, United States 2018. 2018.

  47. Merck Canada Inc. Product monograph-ProQuad. 2016.

  48. GlaxoSmithKline Inc. Product monograph-Priorix-tetra. 2017.

  49. Verolet CM, Posfay-Barbe KM. Live virus vaccines in transplantation: friend or foe? Curr Infect Dis Rep. 2015;17(4):472.

    PubMed  Google Scholar 

  50. Merck Canada Inc. Product monograph-Varivax III. 2016.

  51. GlaxoSmithKline Inc. Product monograph-Varilrix. 2017.

  52. AstraZeneca Canada: Product monograph-Flumist Quadrivalent. 2018.

  53. Feldman AG, Feudtner C, Kempe A. Reducing the underimmunization of transplant recipients. JAMA Pediatr. 2018;172(2):111–2.

    PubMed  Google Scholar 

  54. Ladd JM, Karkazis K, Magnus D. Parental refusal of vaccination and transplantation listing decisions: a nationwide survey. Pediatr Transplant. 2013;17(3):244–50.

    PubMed  Google Scholar 

  55. Torricelli FCM, Watanabe A, Piovesan AC, David-Neto E, Nahas WC. Urologic issues in pediatric transplant recipients. Translat Androl Urol. 2019;8(2):134–40.

    Google Scholar 

  56. Chinnakotla S, Verghese P, Chavers B, Rheault MN, Kirchner V, Dunn T, et al. Outcomes and risk factors for graft loss: lessons learned from 1,056 pediatric kidney transplants at the University of Minnesota. J Am Coll Surg. 2017;224(4):473–86.

    PubMed  Google Scholar 

  57. Viswanathan A, Leffler T, Paloian N, Cain M, McKenna PH. Early transplantation into a vesicostomy: a safe approach for managing patients with severe obstructive lesions who are not candidates for bladder augmentation. J Pediatr Urol. 2018;14(4):332 e1–6.

    Google Scholar 

  58. Riley P, Marks SD, Desai DY, Mushtaq I, Koffman G, Mamode N. Challenges facing renal transplantation in pediatric patients with lower urinary tract dysfunction. Transplantation. 2010;89(11):1299–307.

    PubMed  Google Scholar 

  59. Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006;43(9):705–15.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. van Lieburg AF, de Jong MC, Hoitsma AJ, Buskens FG, Schroder CH, Monnens LA. Renal transplant thrombosis in children. J Pediatr Surg. 1995;30(4):615–9.

    PubMed  Google Scholar 

  61. Ghane Sharbaf F, Bitzan M, Szymanski KM, Bell LE, Gupta I, Tchervenkov J, et al. Native nephrectomy prior to pediatric kidney transplantation: biological and clinical aspects. Pediatr Nephrol. 2012;27(7):1179–88.

    PubMed  PubMed Central  Google Scholar 

  62. Parajuli S, Lockridge JB, Langewisch ED, Norman DJ, Kujovich JL. Hypercoagulability in kidney transplant recipients. Transplantation. 2016;100(4):719–26.

    CAS  PubMed  Google Scholar 

  63. Keller AK, Jorgensen TM, Jespersen B. Identification of risk factors for vascular thrombosis may reduce early renal graft loss: a review of recent literature. J Transplant. 2012;2012:793461.

    PubMed  PubMed Central  Google Scholar 

  64. Kim JK, Chua ME, Teoh CW, Lee MJ, Kesavan A, Hebert D, et al. Assessment of prophylactic heparin infusion as a safe preventative measure for thrombotic complications in pediatric kidney transplant recipients weighing <20 kg. Pediatr Transplant. 2019;23(6):e13512.

    PubMed  Google Scholar 

  65. Müller D, Goldstein SL. Hemodialysis in children with end-stage renal disease. Nat Rev Nephrol. 2011;7(11):650–8.

    PubMed  Google Scholar 

  66. Kim DH, Lee JH, Han DJ, Park YS. Risk factors for persistent hyperparathyroidism in children with stable renal function after kidney transplantation. Pediatr Transplant. 2018:e13238.

  67. Hucker A, Lawrence C, Sharma S, Farrington K. Adherence behavior in subjects on hemodialysis is not a clear predictor of post-transplantation adherence. Kidney Int Rep. 2019;4(8):1122–30.

    PubMed  PubMed Central  Google Scholar 

  68. Hossain M, Woywodt A, Augustine T, Sharma V. Obesity and listing for renal transplantation: weighing the evidence for a growing problem. Clin Kidney J. 2017;10(5):703–8.

    PubMed  PubMed Central  Google Scholar 

  69. Krishnan N, Higgins R, Short A, Zehnder D, Pitcher D, Hudson A, et al. Kidney transplantation significantly improves patient and graft survival irrespective of BMI: a cohort study. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2015;15(9):2378–86.

    CAS  Google Scholar 

  70. Freischlag KW, Chen V, Nagaraj SK, Chua AN, Chen D, Wigfall DR, et al. Psychosocial assessment of candidates for transplantation (PACT) score identifies high risk patients in pediatric renal transplantation. Front Pediatr. 2019;7:102.

    PubMed  PubMed Central  Google Scholar 

  71. De Geest S, Burkhalter H, Bogert L, Berben L, Glass TR, Denhaerynck K, et al. Describing the evolution of medication nonadherence from pre-transplant until 3 years post-transplant and determining pre-transplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss transplant cohort study. Transpl Int. 2014;27(7):657–66.

    PubMed  Google Scholar 

  72. Watschinger B, Budde K, Crespo M, Heemann U, Hilbrands L, Maggiore U, et al. Pre-existing malignancies in renal transplant candidates-time to reconsider waiting times. Nephrol Dial Transplant 2019;34(8):1292–300.

  73. Johnson SR, Cherikh WS, Kauffman HM, Pavlakis M, Hanto DW. Retransplantation after post-transplant lymphoproliferative disorders: an OPTN/UNOS database analysis. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2006;6(11):2743–9.

    CAS  Google Scholar 

  74. Caillard S, Cellot E, Dantal J, Thaunat O, Provot F, Janbon B, et al. A French cohort study of kidney retransplantation after post-transplant lymphoproliferative disorders. Clin J Am Soc Nephrol. 2017;12(10):1663–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  75. Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, et al. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. Pediatr Nephrol. 2018;33:1773–80.

  76. Ding WY, Koziell A, McCarthy HJ, Bierzynska A, Bhagavatula MK, Dudley JA, et al. Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. J Am Soc Nephrol. 2014;25:1342–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Vinai M, Waber P, Seikaly MG. Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review. Pediatr Transplant. 2010;14(3):314–25.

    CAS  PubMed  Google Scholar 

  78. Nehus EJ, Goebel JW, Succop PS, Abraham EC. Focal segmental glomerulosclerosis in children: multivariate analysis indicates that donor type does not alter recurrence risk. Transplantation. 2013;96(6):550–4.

    PubMed  Google Scholar 

  79. Shah L, Hooper DK, Okamura D, Wallace D, Moodalbail D, Gluck C, et al. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients. Pediatr Nephrol. 2019;34(11):2343–50.

  80. Koh LJ, Martz K, Blydt-Hansen TD, Investigators NR. Risk factors associated with allograft failure in pediatric kidney transplant recipients with focal segmental glomerulosclerosis. Pediatr Transplant. 2019;23(5):e13469.

    PubMed  Google Scholar 

  81. Francis A, Trnka P, McTaggart SJ. Long-term outcome of kidney transplantation in recipients with focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2016;11(11):2041–6.

    PubMed  PubMed Central  Google Scholar 

  82. Abbott KC, Sawyers ES, Oliver JD 3rd, Ko CW, Kirk AD, Welch PG, et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis. 2001;37(2):366–73.

    CAS  PubMed  Google Scholar 

  83. Baum MA, Ho M, Stablein D, Alexander SR. North American pediatric renal transplant cooperative S. outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis. Pediatr Transplant. 2002;6(6):488–92.

    PubMed  Google Scholar 

  84. Legendre CM, Campistol JM, Feldkamp T, Remuzzi G, Kincaid JF, Lommele A, et al. Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis. Transpl Int. 2017;30(12):1275–83.

    CAS  PubMed  Google Scholar 

  85. Siedlecki AM, Isbel N, Vande Walle J, James Eggleston J, Cohen DJ. Global a HUSR. Eculizumab use for kidney transplantation in patients with a diagnosis of atypical hemolytic uremic syndrome. Kidney Int Rep. 2019;4(3):434–46.

    PubMed  Google Scholar 

  86. Zuber J, Le Quintrec M, Krid S, Bertoye C, Gueutin V, Lahoche A, et al. Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2012;12(12):3337–54.

    CAS  Google Scholar 

  87. Nürnberger J, Philipp T. Eculizumab for atypical hemolytic–uremic syndrome. N Engl J Med. 2009;360(5):542–44.

  88. Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, et al. Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2019;30:2449–63.

    PubMed  Google Scholar 

  89. Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Fremeaux-Bacchi V, Kavanagh D, et al. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “kidney disease: improving global outcomes” (KDIGO) controversies conference. Kidney Int. 2016;91(3):539–51.

  90. Cochat P, Groothoff J. Primary hyperoxaluria type 1: practical and ethical issues. Pediatr Nephrol (Berlin). 2013;28:2273–81.

    Google Scholar 

  91. Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med. 2013;369(7):649–58.

    CAS  PubMed  Google Scholar 

  92. Jamieson NV, Jamieson KA. Primary hyperoxaluria type 1: gene therapy by liver transplantation. Transplantation. 2009;87(9):1273–4.

    PubMed  Google Scholar 

  93. Brinkert F, Ganschow R, Helmke K, Harps E, Fischer L, Nashan B, et al. Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth. Transplantation. 2009;87(9):1415–21.

    PubMed  Google Scholar 

  94. Perera MT, Sharif K, Lloyd C, Foster K, Hulton SA, Mirza DF, et al. Pre-emptive liver transplantation for primary hyperoxaluria (PH-I) arrests long-term renal function deterioration. Nephrol Dial Transplant. 2011;26(1):354–9.

    PubMed  Google Scholar 

  95. Lee E, Ramos-Gonzalez G, Rodig N, Elisofon S, Vakili K, Kim HB. Bilateral native nephrectomy to reduce oxalate stores in children at the time of combined liver-kidney transplantation for primary hyperoxaluria type 1. Pediatr Nephrol. 2018;33(5):881–7.

    PubMed  Google Scholar 

  96. Villani V, Gupta N, Elias N, Vagefi PA, Markmann JF, Paul E, et al. Bilateral native nephrectomy reduces systemic oxalate level after combined liver-kidney transplant: a case report. Pediatr Transplant. 2017;21(3). https://doi.org/10.1111/petr.12901.

  97. Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, et al. Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant. 2012;27(5):1729–36.

    CAS  PubMed  Google Scholar 

  98. Hoppe B, Kemper MJ, Bokenkamp A, Langman CB. Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria. Kidney Int. 1998;54(3):921–5.

    CAS  PubMed  Google Scholar 

  99. Sanofi Pasteur. Product monograph-Pediacel. 2012.

  100. Novartis. Product monograph-Menjugate. 2013.

  101. Pfizer Canada Inc. Product monograph-NeisVac-C. 2019.

  102. Sanofi Pasteur. Product monograph-Menactra. 2017.

  103. GlaxoSmithKline Inc. Product monograph-Menveo. 2019.

  104. Pfizer Canada Inc. Product monograph-Nimenrix. 2018.

  105. GlaxoSmithKline Inc. Product monograph-Bexsero. 2019.

  106. T.M.Wyeth LLC PCU. Product monograph-Prevnar 13. 2019.

  107. GlaxoSmithKline Inc. Product monograph-Infanrix hexa. 2018.

  108. Kumar D. Immunizations following solid-organ transplantation. Curr Opin Infect Dis. 2014;27(4):329–35.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario, M5G 1X8, Canada

    Chia Wei Teoh, Moira Korus & Valerie Langlois

  2. The Transplant & Regenerative Medicine Centre, The Hospital for Sick Children, Toronto, Ontario, Canada

    Chia Wei Teoh, Moira Korus & Valerie Langlois

  3. Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada

    Chia Wei Teoh & Valerie Langlois

  4. Division of Urology, The Hospital for Sick Children, Toronto, Ontario, Canada

    Armando Lorenzo

  5. Department of Surgery, University of Toronto, Toronto, Ontario, Canada

    Armando Lorenzo

Authors
  1. Chia Wei Teoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Moira Korus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Armando Lorenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Valerie Langlois
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Valerie Langlois.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Renal

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teoh, C.W., Korus, M., Lorenzo, A. et al. Preparing the Child with End-Stage Renal Disease for a Renal Transplant: the Pre-transplant Assessment. Curr Pediatr Rep 8, 134–146 (2020). https://doi.org/10.1007/s40124-020-00225-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40124-020-00225-6

Keywords

Search

Navigation